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Abstract: Phytoestrogens can have a neuroprotective effect towards ischemia-reperfusion-induced
neuronal damage. However, their mechanism of action has not been well described. In this work,
we investigate the type of neuronal cell death induced by oxygen and glucose deprivation (OGD)
and resupply (OGDR) and pinpoint some of the signaling mechanisms whereby the neuroprotective
effects of phytoestrogens occur in these conditions. First, we found that autophagy initiation affords
neuronal protection upon neuronal damage induced by OGD and OGDR. The mammalian target of
rapamycin/ribosomal S6 kinase (mTOR/S6K) pathway is blocked in these conditions, and we provide
evidence that this is mediated by modulation of both the 5′ AMP-activated protein kinase (AMPK)
and phosphatidylinositol-3-kinase/protein kinase B (PI3K/AKT) pathways. These are dampened
up or down, respectively, under OGDR-induced neuronal damage. In contrast, the MAPK-Erk
kinase/extracellular signal-regulated kinase (MEK/ERK) pathway is increased under these conditions.
Regarding the pathways affected by phytoestrogens, we show that their protective properties require
autophagy initiation, but at later stages, they decrease mitogen-activated protein kinase (MAPK) and
AMPK activation and increase mTOR/S6K activation. Collectively, our results put forward a novel
mode of action where phytoestrogens play a dual role in the regulation of autophagy by acting as
autophagy initiation enhancers when autophagy is a neuroprotective and pro-survival mechanism,
and as autophagy initiation inhibitors when autophagy is a pro-death mechanism. Finally, our results
support the therapeutic potential of phytoestrogens in brain ischemia by modulating autophagy.
Keywords: apoptosis; autophagy; brain ischemia; cell signaling; natural antioxidants; neuroprotection;
phytoestrogens
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1. Introduction
Ischemic stroke is the third cause of death worldwide [1]. In this condition, oxygen and glucose
supply to the brain is impaired, causing metabolic distress, which may lead to glutamate-mediated
excitotoxicity [2] and cell death in the core of the lesion, whereas the penumbra becomes functionally
silent but remains structurally intact [3]. Three ways of cellular death have been implicated in
stroke: necrosis, apoptosis, and, most recently, autophagy. Necrosis predominates in the ischemic
core, whereas apoptosis and autophagy are often observed in the penumbra after focal ischemia [3].
The relationship between these three types of death in ischemia is not clear. Despite improvements in
stroke management over the last decade, mainly due to the use of thrombolysis, there is no effective
neuroprotective treatment against the acute phase of stroke [1,4].
Autophagy has emerged in recent years as an essential mechanism for maintaining cellular
homeostasis and as part of the cellular response to stress [5,6]. However, numerous reports have
documented that both ischemia- and reperfusion-induced excessive autophagy activation leads to
neuronal death through unknown mechanisms [7,8]. Nonetheless, autophagy can be protective
during post-stroke recovery by diminishing the degeneration of disrupted neurites, clearing damaged
mitochondria, and stopping apoptosis and necrosis [9].
The increasing knowledge about the ischemic cascade has led to a considerable development of
pharmacological tools, suggesting that each step of this cascade might be a target for cytoprotection.
Thus, many neuroprotective drugs such as calcium channel blockers [10], antioxidants or free radical
scavengers [11,12], gamma-aminobutyric acid (GABA) agonists, glutamate antagonists, NO inhibitors,
growth factors, anti-inflammatories, and phosphatidylcholine precursors as citicoline [12,13] have been
studied in experimental stroke models and stroke patients. However, very few have shown efficacy in
clinical trials. Among them, caspase inhibitors [14] to reduce apoptosis and estrogens or its derivatives,
phytoestrogens [15,16], have been proposed as future neuroprotective agents.
In vivo and in vitro studies have demonstrated the powerful neuroprotective effects of estrogens
against a variety of ischemic insults [16–18], which appear to use multiple mechanisms depending on
the injury.
Interestingly, it is increasingly clear that physiological doses of isoflavones can mimic some of the
neuroprotective effects of estrogens [19,20]. Phytoestrogens are a group of plant-derived compounds
that mainly comprise isoflavones. It has been shown that phytoestrogens prevent neuronal damage
and improve the outcome under experimental stroke conditions [21–23]. Emerging findings suggest
that phytoestrogens have the ability to target multiple pathophysiological processes involved in
stroke, including oxidative stress, inflammation, and apoptotic cell death [24–27]. Furthermore,
epidemiological studies suggest that the consumption of plant sources rich in phytochemicals may
reduce stroke risk, which reinforces the possibility of developing preventive or neuroprotective
therapies for stroke [28]. However, the mechanism of action whereby these compounds exert their
neuroprotective effects is poorly understood. Importantly, in the majority of published works, estrogens
and phytoestrogens were studied as neuroprotective agents, but their possible effects on neurorepair in
the post-ischemic period have not been described, and it is at this point where protection is necessary
after an ischemic event.
Recent results reported by Oset-Gasque et al. demonstrated that the phytoestrogen Genistein
may protect neurons against oxygen and glucose deprivation (OGD) and resupply (OGDR) by
attenuating oxidative stress, lipid peroxidation, and necrotic cell death [29]. Moreover, genistein can
also reduce necrosis and increase neurons viability by modulating autophagy [29]. They also observed
a decrease in reactive species of oxygen (ROS) due to a regulation of hypoxia inducible factor α (HIFα),
which could control the activation of autophagic proteins such as Beclin1 and Bcl2 and adenovirus E1B
19 kDa-interacting protein 3 (BNIP3). Recent results have also demonstrated that the phytoestrogen
Daidzein has cytoprotective properties in neurons, which are due to an increase in peroxisome
proliferator-activated receptor gamma (PPARγ) activity [30]. The phytoestrogen Genistein exhibited
neuroprotective effects following ischemic stroke in rats by targeting NF-κB signaling and possibly
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by inhibiting downstream inflammatory immune cells in the brain [31]. Similarly, the phytoestrogen
biochanin A provided neuroprotection against cerebral ischemia-reperfusion injury by Nrf2-mediated
inhibition of oxidative stress and inflammation signaling pathway in rats [32]. All in all, these results
indicate that genistein, biochanin A, and daidzein could have a therapeutic potential in neuroprotection
and neurorepair.
The present study focuses on the potential neuroprotective effects and the mechanism of action of
phytoestrogens genistein and biochanin A, compared to estrogens (17β-estradiol). To this end, neuronal
primary cultures were subjected to OGD and OGDR to investigate the involvement of autophagy and the
signaling pathways of mitogen-activated protein kinase (MAPK), phosphatidylinositol-3-kinase/protein
kinase B (PI3K/AKT), and 5′ AMP-activated protein kinase/ mammalian target of rapamycin/p70
ribosomal S6 kinase (AMPK/mTOR/p70S6K) as potential mediators of the neuroprotective effects
exerted by phytoestrogens against this type of damage.
2. Materials and Methods
2.1. Primary Cortical Neuron Cultures
Cortical neurons were obtained from fetal Wistar rat brains at gestation day 19, following the
procedure described in [33], with minor modifications. In these experiments, all animal handling
was performed in accordance with European Commission guidelines (2010/63/UE) and was approved
by the Animal Research Committee at the Complutense University (ethical code: PROEX012/18).
Briefly, after eliminating meninges and blood vessels, the brain cortex was homogenized in HBSS
medium (Hanks Buffer Salt Solution 1X, Gibco, Thermo Fisher Scientific, Madrid, Spain), and filtered
in a falcon tube with a filter (54 µm). The tissue homogenate was washed by centrifugation twice
with a Krebs-HEPES solution (Locke’s calcium-free medium) containing (in mM) NaCl 140, KCl 4.7,
KH2PO4 1.2, glucose 5.5, ascorbic acid 0.5, EGTA 1 and HEPES 10, pH 7, and once with Dulbecco’s
Modified Eagle’s Medium (DMEM) F12-Glutamax (Gibco, Thermo Fisher Scientific, Madrid, Spain).
After counting, cells were seeded in DMEM F12-Glutamax containing 10% fetal bovine serum (FCS) and
1% of a mix of antibiotics and antimycotics (Gibco® Antibiotic-Antimycotic, Thermo Fisher Scientific,
Madrid, Spain). This solution containing 10,000 units/mL of penicillin, 10,000 µg/mL of streptomycin,
and 25 µg/mL of Fungizone®. Cells were then plated in poly-D-lysine (0.04 mg/mL, Sigma Aldrich,
Madrid, Spain)-coated plates and then incubated in a 5% CO2 atmosphere at 37 ◦C. After 3–4 d,
the medium was changed, and 1% B27 supplement (Gibco, Thermo Fisher Scientific. Madrid, Spain)
was added to the culture medium instead of FCS. Cells were seeded at different densities depending
on the type of experiment performed.
2.2. Oxygen and Glucose Deprivation (OGD) and Resupply (OGDR)
For this study, we used an in vitro OGD and OGDR model, where cultured cells were subjected
to short-term oxygen and glucose deprivation, followed by subsequent resupply of these. Ischemia
represents the interruption of metabolic fuel and oxygen delivery to support cellular oxidative
metabolism, and reintroduction of oxygen upon reperfusion of ischemic tissue triggers oxidative stress,
which initiates the reperfusion injury cascade culminating in injury and death of cells and tissues [34].
Thus, cultured cells subjected to hypoxia, fuel deprivation, and reoxygenation replicate the cardinal
features of ischemia–reperfusion. This is a commonly used model to investigate changes in gene and
protein expression associated with this type of insult, as well as to test the neuroprotective properties
of drugs and their molecular effects on signaling pathways. These detailed studies are not as feasible
using more complex systems, especially intact animals [34].
Thus, firstly, cells were subjected to OGD [29]. The DMEM F12 Glutamax was replaced with DMEM
glucose-free medium and transferred to an anaerobic incubator in a 95% N2/5% CO2 atmosphere at
37 ◦C for 3 h. At the end of this period, the cells were treated for 6–24 h, as indicated, with drugs. For this
purpose, the glucose-free medium was replaced with the DMEM F12 Glutamax, a medium containing
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glucose with the mixture of antibiotics/antimycotics (1%) and B27 supplement (1%; culture medium)
and cells were kept in a normoxic incubator (95% Air/5% CO2 atmosphere at 37 ◦C). The treatment
with phytoestrogens was always done after the OGD period, that is, during the OGDR treatment.
The compounds used were genistein (Gen), biochanin A (BioA), and 17-β estradiol (BE) (all of them
from Sigma Aldrich, Madrid, Spain) at concentrations between 0.001–100 µM, as indicated in each
experiment. For autophagy inhibition, 5 mM 3-methyladenine (3-MA; Sigma Aldrich, Madrid, Spain)
was used. Inhibitors of cellular pathways LY294002 (AKT inhibitor) and PD98059 (MEK inhibitor)
(Calbiochem, Sigma Aldrich, Madrid, Spain), at 1µM, were used. Control plates were kept in the
normoxic incubator (95% Air/5% CO2 atmosphere at 37 ◦C) for the same time period of the OGD and
then replaced with the DMEM F12-Glutamax fresh medium.
2.3. Western Blotting
For these experiments, cells were seeded in 5 cm Petri dishes Falcon® (CULTEK, S.L.U., Madrid,
Spain) at a density of 106 cells/mL.
Cell extracts were prepared using a lysis buffer containing 1% Triton, 10 mM Tris, 5 mM
EDTA, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM NaF, 100 µM orthovanadate, 500 µM
phenylmethylsulfonyl fluoride, 5 µg/L aprotinin, and 0.025 µg/L leupeptin, pH 7.4. After scraping the
plates, lysates were used to measure proteins concentration with the Bradford method. The samples
were heated for 10 min at 95 ◦C and then separated with electrophoresis in 10% polyacrylamide
gels. Subsequently, the proteins were transferred to a nitrocellulose membrane. After blocking the
non-specific sites with TBST (Tris-Buffered Saline, 0.1% Tween® 20 Detergent) and milk 5% for 1 h,
the membranes were incubated with primary antibodies. The immunodetection was made by enhanced
chemiluminescence (ECL) of luminol, after incubating the secondary antibodies. All the antibodies
used for these experiments, as well as the used dilutions, are indicated in Table 1A.
2.4. Immunocytochemistry
Cells were seeded in 24-well plates on glass coverslips and treated with phytoestrogens at 1 µM to
observe the expression of microtubule-associated protein light chain 3B (LC3B) and βIII Tubulin (B3T).
Every treatment was performed in the absence or presence of 5 mM 3-MA. After 24 h, the medium was
removed, cells were washed with phosphate-buffered saline (PBS) and fixed with 4% paraformaldehyde
in PBS for 15 min. Coverslips were stored at −80 ◦C in solution cryoprotectant (30% ethylene glycol,
30% glycerol, 40% 0.1M phosphate buffer). Cells were washed again with PBS before immunodetection.
The following antibodies were used (Table 1B). Coverslips were washed three times with PBS and then
mounted on glass slides with Prolong Antifade from Invitrogen (Thermo Fisher Scientific, Madrid,
Spain), a reagent that suppresses photobleaching and preserves the signals of fluorescently labeled
target molecules for long-term storage and analysis. Preparations were allowed to dry for at least
24 h before performing detailed observation under the confocal microscope. LC3B fluorescence was
quantified by fluorescence microscopy. Quantification of autophagosome-like LC3B labeled dots was
performed by measuring dot intensity with the Image J program and normalized as a percentage of
the total cells present in a field as counted by the total number of nuclei (DAPI+). Then, 30–40 cells per
image were analyzed; n = 10 images from 2 different cultures, per each condition. Data are expressed as
mean ± SEM. Statistical analysis was done by Student’s t-test. Differences were accepted as significant
if p < 0.05.
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Table 1. Antibodies (Ab) used for western blot and immunocytochemistry assays.
Assay Type Primary Ab Concentration Producer MW (kDa) Secondary Ab Concentration Producer
(A) Western Blot
Rabbit-anti LC3B 1/1000 Cell Signalling 16, 14 HRP-conjugatedgoat anti-rabbit 1/1000 Sigma-Aldrich
Rabbit-anti caspase 3
Rabbit-anti-Cleaved-casp. 3 1/1000 Cell Signalling 32, 19, 17
HRP-conjugated
goat anti-rabbit 1/1000 Sigma-Aldrich
Rabbit-anti mTOR
Rabbit-anti Ser2448P-mTOR 1/1000 Cell Signalling 285
HRP-conjugated
goat anti-rabbit 1/1000 Sigma-Aldrich
Rabbit-anti AMPKα
Rabbit-anti Thr172P-AMPK 1/1000 Cell Signalling 62
HRP-conjugated
goat anti-rabbit 1/1000 Sigma-Aldrich
Rabbit-anti p70S6K
Rabbit-anti Thr389P-p70S6K 1/1000 Cell Signalling 70, 85
HRP-conjugated
goat anti-rabbit 1/1000 Sigma-Aldrich
Rabbit-anti AKT
Rabbit-anti Ser473P-AKT 1/1000 Cell Signalling 60
HRP-conjugated
goat anti-rabbit 1/1000 Sigma-Aldrich
Rabbit-anti
Thr202/Tyr204P-MAPK42,44 1/1000 Cell Signalling 42, 44
HRP-conjugated
goat anti-rabbit 1/1000 Sigma-Aldrich
Rabbit-anti Beclin-1 1/1000 Cell Signalling 60 HRP-conjugatedgoat anti-rabbit 1/1000 Sigma-Aldrich
Rabbit-anti BNIP3 1/1000 Cell Signalling 30 HRP-conjugatedgoat anti-rabbit 1/1000 Sigma-Aldrich
Mouse-anti β-Actin 1/6000 Sigma-Aldrich 42 HRP-conjugatedgoat anti-mouse 1/4000 Sigma-Aldrich
(B) Fluorescence
Immunocytochemistry
Rabbit-anti LC3B 1/300 Cell Signalling 16, 14 Donkey anti-rabbitAlexa Fluor 488 1/300 Sigma-Aldrich
DAPI 1/1000 Sigma-Aldrich 277.3 - - -
MW: molecular weight; LC3B: microtubule-associated protein light chain 3B; DAPI: 4′,6-diamidino-2-phenylindole.
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2.5. RT-PCR Analysis
2.5.1. RNA Extraction
The RNeasy Mini Kit from Applied Biosystems (Thermo Fisher Scientific, Madrid, Spain) was
used for total RNA isolation. Reverse transcription (RT) was carried out for one hour at 55 ◦C with
oligodeoxythymidylate primer, using 5 µg of total RNA from each sample for complementary DNA
synthesis. Real-time quantitative PCRs were performed in order to determine the levels of Beclin 1
(Becn1) and BNIP3, as well as housekeeping β-actin (β-Act) mRNAs by using the following specific
primers synthesized at Sigma-Aldrich Co. (Madrid, Spain) (Table 2).








βAct: β-Actin; Becn1: Beclin 1; BNIP3: Bcl2 and adenovirus E1B 19 kDa-interacting protein 3.
2.5.2. Real-Time q-PCR
The SYBR Green PCR Master Mix (Applied Biosystems, Thermo Fisher Scientific, Madrid, Spain)
and the 7900 HT Fast Real-Time PCR system (Applied Biosystems, Thermo Fisher Scientific, Madrid,
Spain) were used to detect the real-time quantitative PCR products of the reverse-transcribed cDNA
samples, according to the manufacturer’s instructions. q-PCR conditions were 95 ◦C (10 min), followed
by 40 cycles of 15 s at 95 ◦C and annealing for 1 min at 60 ◦C. Three independent quantitative PCR
assays (RT+) were performed for each gene and measured in triplicate. Three no-template controls
(NTCs) were run for each quantitative PCR assay, and genomic DNA contamination of total RNA was
controlled using three RT-minus controls (RT−) (samples without the reverse transcriptase).
Results are expressed as relative quantification (RQ), which was calculated from cycle thresholds
(CTs) from each studied gene and housekeeping gene by means of the equation:
RQ = 2−∆(∆Ct), where ∆(∆Ct) = ∆Ct(target gene) − ∆Ct(calibrator gen) (1)
2.6. Cell Viability Test XTT
The XTT test (Cell Proliferation Kit II (XTT), Roche Diagnostics GMBH, Mannheim, Germany)
is a colorimetric assay that allows nonradioactive spectrophotometric quantification of cell growth
and viability without the use of radioactive isotopes. It is based on the ability of the cells to break the
tetrazolium salts (yellow) by the action of mitochondrial dehydrogenases to form salts of formazan
(orange), soluble in aqueous solutions, which are quantified spectrophotometrically. Therefore,
an increase in the number of viable living cells reflects an increased activity of the mitochondrial
dehydrogenase, which is directly correlated to the amount of orange formazan salt formed, increasing
the absorbance of the sample.
Cells were seeded in 48-wells plates at a concentration of 250,000 cells in 500 µL/well of DMEM
F12-Glutamax supplemented with 1% B27. In this medium, cells were incubated with the appropriate
drugs for 24 h. Then, the medium was removed from the culture, and the cells were washed twice with
fresh DMEM F12-Glutamax without B27-supplement. After this, 100 µL/well of yellow XTT solution
(prepared by mixing 5 mL of the XXT labeling reagent and 0.1 mL of the electron coupling reagent,
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as described in the kit protocol, at a concentration 0.3 mg/mL) was added to the cells in a final volume
of 200 µL of medium, and incubation was carried out for a maximal time of 4 h. During this time,
absorbance measurements were performed at a time interval of 1 h. Spectrophotometric quantification
was performed on a Biotek Power-Wave XS spectrophotometer microplate-reader (BioTek Instruments,
Madrid, Spain) at a wavelength of 490 nm, using as reference a wavelength of 690 nm. Fitting of
the concentration/response curves for estimation of EC50 values was made by weighted nonlinear
regression of minimum squares, using logistic curves.
2.7. Caspase 3 Activity Test
Cells were seeded in 48-well plates in 500 µL of DMEM F12-Glutamax at a concentration of
250,000 cells/well. After a week of growth, control plates were changed with fresh culture medium,
while experimental plates were changed with glucose-free medium and subjected to OGD for 3 h. Then,
cells were put in the DMEM F12 Glutamax, glucose-containing medium and exposed to the treatments
with drugs for 24 h. The protective effects of 1 µM phytoestrogens (1 µM) on apoptosis induced by
OGDR were studied. In the control plates, the effects of culture medium alone (C24h) and DMSO (10%,
1%, 0.1%, 0.01%), which was used to dissolve the drugs, were studied. After 24 h of exposition to the
treatments in a 95% air 5% CO2 atmosphere, the medium was removed, and the wells were washed
with 300 µL of PBS. Then, 200 µL of caspase lysis buffer (10 mM Tris-HCl, 10 mM NaH2PO4/Na2HPO4,
pH 7.5, 130 mM NaCl, 0.5% Triton X-100, 10 mM Na4P2O7, and 2 mM dithiothreitol (DTT) were added
to the cells, and they were scraped. The suspension was put in an eppendorf tube and left in ice for
15 min. Finally, after centrifugation for 10 min at 13,000 rpm, the supernatant was stored at −80 ◦C.
To test the activity of caspase 3, the substrate N-acetyl-Asp-Glu-Val-AMC (7-amino-4-methylcoum
arin) was used. It is stored lyophilized in PBS, and was prepared by adding 1 mL of water per mg.
The buffer used for protease assay was 10 mM HEPES (pH 7.5, Sigma Aldrich, Madrid, Spain), 10%
glycerol, and 2 mM DTT. The DTT was added just before using the buffer.
Caspase-3 activity was measured in the control and treated cortical neurons supernatants.
Supernatants with at least 20 µg of protein (10–100 µL of lysates) were incubated at 37 ◦C for 2–4 h in
1 mL of caspase-3 assay buffer (20 mM HEPES, pH 7.5, 10% glycerol, 2 mM DTT) containing 20 µM
Ac-DEVD-AMC [N-acetyl-Asp-Glu-Val-Asp-(7-amino-4-methylcoumarin)]. The fluorogenic AMC
liberated from Ac-DEVD-AMC was monitored using a spectrofluorometer (Bio-Tek FL 600, BioTek
Instruments, Madrid, Spain), with an excitation wavelength of 360 nm and an emission wavelength
range of 460 nm. Under these conditions, the emission was linear between, at least, 0–6 h, depending
on the caspase-3 activity. Enzymatic activity is expressed as arbitrary fluorescence units (AFU) after
1 h per mg protein (AFU/h/mg protein).
2.8. Statistics
Data were expressed as means ± SEM values of three or four independent experiments with
different cell batches, each of which was performed in duplicate or triplicate. Statistical comparisons
were performed by using one-way analysis of variance (ANOVA), followed by Holm−Sidak’s post-test
when the analysis of variance was significant. Differences were accepted as significant if p < 0.05.
Statistical analyses and fit curves for EC50 determinations were carried out using SigmaPlot 11.0
software (Systat Software, Inc., Erkrath, Germany). Statistical analysis for immunocytochemistry was
done by Student’ t-test. Differences were accepted as significant if p < 0.05.
3. Results
3.1. Early Autophagy Activation Plays a Protective Role in Primary Cortical Neurons upon Experimental OGD
and OGDR
Previous experiments of our research group suggested the involvement of different cell death
pathways in OGD-induced neuronal death, including necrosis, apoptosis, and autophagy [29].
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To determine if autophagy activation represents a pro-survival or a pro-death response during
OGD damage, we tested the ability of 3-MA, a well-established inhibitor of autophagy initiation
based on its inhibitory effect on class III PI3K activity, which is known to be essential for induction of
autophagy [35], to affect cell death of primary neurons subjected to 3 h OGD and subsequent OGDR.
First, Western blot analysis of LC3B, which is a well-documented indicator of autophagy activation [36],
was carried out. LC3B data were normalized against β-Actin (BA) as a housekeeping gene, instead
of microtubule-associated protein light chain 3B-I (LC3B-I), as this is currently considered as a more
accurate autophagy indicator [37]. Results from Figure 1A,B show that OGD and OGDR induced an
increase in LC3BI lipidation, which is reflected by the significant increase in microtubule-associated
protein light chain 3B-II (LC3B-II/BA) ratio in both conditions. 3-MA had a small or nonsignificant
effect on controls but, as expected, significantly reduced the increase in LC3B-I lipidation upon OGD
and OGDR (Figure 1A). Therefore, these results demonstrated that 3-MA efficiently decreases OGD-
and OGDR autophagy induction in primary cortical neurons.
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Figure 1. Effect of oxygen and glucose deprivation (OGD), oxygen and glucose deprivation and
resupply (OGDR), and 5 mM 3-methyladenine (3-MA) treatment on LC3B lipidation (A,B) and mTOR
and p70S6K phosphorylation (C,D) in cultured cortical neurons. (A,B) Western blot analysis of LC3BI
and LC3BII was performed in extracts of cortical neurons subjected to 3 h OGD exposure (O) and
subsequent 24 h OGDR (OR) compared to their respective controls. (A) Representative LC3B I and II
and β-actin (BA) Western blots are shown. (B) Quantitative analysis of the LC3BII/BA ratio. Data are
expressed as ratios over basal control and are mean ± SEM of three experiments, each one performed
in duplicate. (C,D) Western blots of mTOR, 2448SerP-mTOR, and 389ThrP-p70S6K were performed
in the aforementioned conditions. Upper panel (C) shows a representative Western blot of these
proteins. Lower panels (D) shows the quantification of the indicated ratios and are mean ± SEM of
three experiments, each one performed in duplicate. Statistics in panels (B) and (D) compare the effect
of O and OR over their respective controls C3 and C24h, respectively (***) and the effect of 5 mM 3-MA
in each condition, in the absence or presence of this compound (ooo), at */o p < 0.05, **/oo p < 0.01,
and ***/ooo p < 0.001) (one-way ANOVA test).
In addition, we performed fluorescence image analysis of LC3B and found that LC3B-labeled dots
increased upon OGDR compared to control cells (182.04 ± 12.93% and 100.71 ± 9.25%; mean ± SEM,
for OGDR and C24h, respectively, p < 0.01 Student’s t test; Figure S1A,B). 3-MA treatment markedly
diminished LC3B labeling versus the OGDR condition alone (76.73 ± 8.92%; p < 0.001 Student’s t test;
Figure S1C).
It is well-known that autophagy is canonically inhibited when mTOR is activated by
phosphorylation at 2448Ser. Consequently, when mTOR is inactive, autophagy can be engaged [6].
This autophagy-activating mechanism was also studied upon experimental OGD and OGDR conditions.
We found that the phosphorylation of both 2448SerP-mTOR and 389ThrP-p70S6K, a well-known
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downstream substrate of mTOR that regulates protein synthesis [38], decreased upon OGD and/or
OGDR, which are largely reverted by 3-MA (Figure 1C,D). Overall, these results show that autophagy
activity becomes enhanced upon early OGD and is maintained during OGDR, both of which are
abolished upon 3-MA treatment.
To determine whether these autophagy changes represent a pro-survival or pro-death effect,
we next investigated the effect of 3-MA on cultured neuron viability subjected to OGD and OGDR.
First, we compared the metabolic activity of primary neurons subjected to control, OGD, or OGDR
conditions using the XTT assay and found that OGD strongly diminished metabolic activity, which was
partially mitigated in OGDR conditions (Figure 2A).
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Figure 2. Effect of 3-methyladenine (3-MA) on cell viability and apoptosis of cortical neuron cultures
under OGD and OGDR conditions. (A) Effect of 3-MA on cell viability measured by XTT assay.
(B) Effect of 3-MA on caspase-3 activity. Both measurements were performed in extracts of cortical
neurons subjected to 3 h OGD exposure (O) and 24 h OGDR (OR). Basal caspase-3 activity (C3h) was
3.58 ± 0.05 ∆AFU/h/µg protein. (C) Effect of 5 mM 3-MA on caspase-3 proteolysis in cortical neuron
cultures under control conditions (C3 and C24) and OGD (O) and OGDR (OR) treatments. Western blots
(CASP3 32 kDa; tCasp3 = total caspase 3) and cleaved (CASP3 19,17 kDa; pCasp3 = proteolyzed caspase
3) were performed in extracts of cortical neurons subjected to 3 h OGD exposure and 24 h OGDR,
using two different anti CASP3 antibodies. Left: Representative CASP3 Western blots are shown. Right.
Quantification of Western blot results showing the ratios between Casp3p = proteolyzed caspase and
Casp3t = total caspase 3. Data are expressed as ratios over basal control and are mean ± SEM of three
experiments, each of which was performed in triplicate (A,B) or duplicate (C). Statistics compare the
effect of O and OR versus their respective controls (***) or the effect of 5 mM 3-MA under each condition
versus respective conditions in the absence of this compound (ooo) at o p < 0.05, oo p < 0.01, ooo p < 0.001;
one-way ANOVA test) are shown. C3h: control 3h; C24h: control 24h; OR24h: OGDR 24h; OMA: OGD
plus 3-MA; ORMA: OGDR plus 3-MA; C3: control 3h; MA3: 3-MA 3h; MA24: 3-MA 24h.
Moreover, while 3-MA treatment had no statistically significant effect in control conditions,
it significantly decreased metabolic activity upon both OGD and OGDR, suggesting the initiation of
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autophagy plays a protective role. Second, we found that the activity of caspase 3, a key mediator of
apoptosis, increased upon both OGD and OGDR, and was further exacerbated by 3MA (Figure 2B).
To further confirm this result, we measured the enzymatically active proteolyzed forms of caspase 3
and found that 3-MA also exacerbated the production of activated caspase-3 induced by OGD and
OGDR (Figure 2C). Altogether, these results show that the inhibition of autophagy initiation increases
apoptosis under OGD conditions and, therefore, supports a pro-survival effect for early autophagy
activation that protects OGD-subjected neurons from apoptotic cell death.
3.2. Phytoestrogens Afford Neuroprotection by Modulating Autophagy
To characterize the neuroprotective effect of the phytoestrogens in experimental OGDR,
these phytoestrogens were added following OGD. Firstly, the effects of different doses of phytoestrogens
on cell viability, on their own or in combination with 3-MA, were tested. The phytoestrogens used were
Gen, and BioA, while BE was used as a reference compound as it is a pure agonist of estrogen receptors
(ERs). Exposure to 0.001–100 µM of these compounds within 24 h of OGDR significantly reverted
the OGDR-induced decrease in metabolic activity in a concentration-dependent manner (Figure 3A).
The analysis of the % neuroprotection curves at the indicated concentrations revealed EC50 = 0.164
± 0.016, 0.381 ± 0.017, and 0.062 ± 0.003 µM for Gen, BioA, and BE, respectively, indicating that the
order of neuroprotective potency of these compounds is BE > Gen > BioA (p < 0.01, one-way ANOVA
test). In addition, 3-MA treatment significantly reduced the neuroprotective effects of phytoestrogens
and BE (Figure 3B), suggesting that phytoestrogens modulate autophagy to afford neuroprotection.
In agreement with these findings, the phytoestrogens were able to significantly decrease caspase 3
activity induced by OGDR, the order of potency being BE > BioA > Gen. However, this antiapoptotic
effect was dramatically abolished on exposure to 3-MA (Figure 3C). Altogether, these results indicate
that the phytoestrogens, similar to BE, are neuroprotective upon OGDR conditions and that this effect
is dependent on their modulation of autophagy initiation.
To determine whether the phytoestrogens modulate the expression levels of canonical autophagic
proteins to afford neuroprotection, we measured the protein levels of the autophagy-initiating proteins
Beclin1 and BNIP3 [39]. We decided to focus on Gen as this is a well-characterized phytoestrogen and
because both Gen and BioA had a similar neuroprotective effect (Figure 3A–C).
Gen and BE treatment reduced the expression of Beclin-1 and BNIP3 at 24 h of OGDR,
which was further enhanced by 3-MA treatment (Figure 3D,E). As explained in the discussion
section, these inhibitory effects of phytoestrogens could be due to the fact that the mRNA expression
of these autophagy-regulators genes was variable throughout time, such that it increased at 6 and
12 h after OGDR initiation in the case of Becn1 and BNIP3 mRNA expression, respectively, yet it
decreased later on at 24 h of OGDR (Figure S2A,B). The differences in the times observed for the
activating effects of phytoestrogens in the case of Becn1 and BNIP3 may be due to the fact that the
mRNA levels of Becn1 drop more slowly than those of BNIP3 during OGDR, with the activating effect
of the phytoestrogens being observed at 6 h of oxygen and glucose resupply, while in the case of BNIP3,
the levels of mRNA expression decrease sharply after 6 h of OGDR and slightly recover at 12 and 24 h,
and the activating effect of phytoestrogens is observed later at 12 h of OGDR. However, the inhibitory
effect of phytoestrogens is seen in both cases at long OGDR times (24 h), when the mRNA expression
levels of both genes are lower.
Collectively, these results indicate that the phytoestrogens positively modulate autophagy initiation
early during OGDR, whereas at longer times, at least after 24 h of OGDR, phytoestrogens act as mild
inhibitors of autophagy initiation. As further explained in the discussion section, these results suggest
that autophagy may play a dual role during OGDR and that lowering autophagy at longer OGDR
times is beneficial.
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Figure 3. Neuroprotective effect of phytoestrogens on the decrease in cell viability, apoptosis,
and autophagy (BNIP3 and Beclin 1 expression) induced by OGDR in cortical neuron cultures:
Effect of 3-MA. (A) Dose–response curves of the neuroprotective effect afforded by 0.001–100 µM
concentrations of phytoestrogens on the decrease in neuronal viability (metabolic activity) induced by
OGDR (OR). The data are the means ± SEM of three determinations, each one performed in triplicate.
Data analysis was performed with SigmaPlot 11 (see Section 2). (B) Effect of 5 mM 3-MA on the
neuroprotective effect of Gen, BioA, and 17βE at 1–10 µM concentrations. Cell viability (metabolic
activity) was measured by the XTT method. Data are expressed as percentages of cell viability of basal
controls (100%) and are mean ± SEM of three experiments, each of which was performed in triplicate.
In (B) the statistics compare the effect of the indicated compounds over OR alone (***) or the effect of
5 mM 3-MA treatments over their respective controls in the absence of this compound (o o) at o p < 0.05,
oo p < 0.01, ooo/*** p < 0.001 (one-way ANOVA test). (C) Neuroprotective effect of phytoestrogens on
the increase in apoptosis induced by OGDR. Effect of 5 mM 3-M on the neuroprotective effects of
Gen, BioA, and BE at 1 µM concentratio . CASP 3 activity was measured as indicated in Material
and Methods. Data are expressed as ∆AFU/h/µg protein a d are mean ± SEM of three experiment ,
each of which was perform d in triplicate. Statistics comparing the effect of i icated compounds
ov r OR condition alone (***) or t e effect of 5 M 3-MA treatments over their respective controls in
the abs n e of this compound (ooo) a ** p < 0.01, **/ooo p < 0.001 (one-way ANOVA t st) are shown.
(D,E) Eff cts of 1 µM genistein (Gen) or 17-β-estradiol (BE) on the expression of BNIP3 and Becn1
proteins. Upper panels show representative Western blots and lower panels represent the quantitative
analysis of data expressed as ratios over basal control and are mean ± SEM of three experiments, each
of which was performed in duplicate. Statistics comparing the effect of OR alone over its control and in
the presence of phytoestrogens (***) and the effect of 5 mM 3-MA in each condition versus respective
controls in the absence of this compound (ooo) (* p < 0.05, oo p < 0.01, ***/ooo p < 0.001; one-way
ANOVA test) are shown. G: 1 µM genistein; GMA: 1 µM genistein plus 3-MA; BE: 1 µM 17-β-estradiol;
BEMA: 1 µM 17-β-estradiol plus 3-MA.
3.3. Phytoestrogens Activate mTOR and Act as MEK Inhibitors in Advanced Stages of OGDR
We found that autophagy increases during OGDR conditions, which is concomitant with decreased
mTOR activity (Figure 1C,D). Since phytoestrogens lower autophagy initiation after 24 h of OGDR
(Figure 3D,E), we next tested whether this was linked to changes in mTOR activity. Treatment with
Gen increased 2448Ser-mTOR phosphorylation (Figure 4A,B). To exclude that this was a Gen-specific
effect, we also tested the effect of BioA and BE as a positive control on mTOR phosphorylation during
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OGDR, and found that both compounds also increased 2448Ser-mTOR phosphorylation (Figure 4A,B).
In combination with 3-MA, there was no further increase in 2448Ser-mTOR phosphorylation, suggesting
that both 3-MA and the phytoestrogens can activate mTOR with similar efficiency (Figure 4A,B).
Altogether, these results indicate that phytoestrogens can prime mTOR to be more active in the late
stages of OGDR, which is probably directly linked to their effect on autophagy-initiating proteins and
their neuroprotective properties.
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Figure 4. Effects of OGDR, phytoestrogens, and 3-MA treatment on mTOR and AMPK phosphorylation.
Western blots of mTOR, 2448SerP-mTOR (A,B), and 172Thr-P- MPK (C,D) were performed in extracts
of cortical neurons exposed to 3 h OGD exposure (O) and 24 h OGDR (OR) in the absence or presence
of 5 mM 3-MA (A,B) or under OR conditions in the absence or presence of 1 µM Genistein (Gen),
BiocaninA (BioA), and 17-β-estradiol (BE)). Upper panels (A,C) show representative Western blots.
Lower panels (B,D) represent the quantitative analysis of indicated ratios and are mean ± SEM of three
experiments, each one performed in duplicate. Statistics comparing the effect of 5 mM 3-MA in each
condition versus respective conditions in the absence of this compound (ooo) panel (B), the effect of O
and OR over control C3 (***) panel (D), and the effect of phytoestrogens on OR condition without them
(***) panels (B,D), at * p < 0.05, ** p < 0.01, and *** p < 0.001 (one-way ANOVA test) are shown.
In order to know if the AMP-activated protein kinase (AMPK), a sensor of intracellular energy
which inhibits mTOR phosphorylation, is involved in phytoestrogens-induced mTOR activation,
the effect of OGDR and Gen, BioA, and BE was analyzed. As shown in Figure 4C,D, there was an
increase in AMPK phosphorylation in OGD conditions, which was significantly reduced during OGDR,
as expected. In these conditions, Gen, BioA, and BE were able to further reduce AMPK phosphorylation
induced by OGDR, indicating that this pathway could be involved upstream in the inhibition of
mTOR/S6K phosphorylation not only during OGDR but also as part of the neuroprotective effect
of phytoestrogens.
We also investigated the involvement of the AKT and MEK pathways as upstream mTOR
regulatory pathways in the effect of phytoestrogens, for which we again focused on the effects of
Gen and BE. To this end, 473SerP-AKT was used as the active form of this kinase [40] and p-MAPK
(p44/42)(Thr202/Tyr204) as an indicator of MEK activity. We found that the pAKT/AKT ratio decreases
under OGD and OGDR conditions compared to controls (Figure 5A,B). In addition, 3-MA treatment
inhibited AKT phosphorylation in controls, yet it remained unchanged upon OGD and OGDR
(Figure 5A,B). Regarding the MEK/ERK1/2 pathway, both OGD and OGDR increased MAPK 42/44
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phosphorylation, and 3-MA did not have any effect under OGD conditions (Figure 5A,B). Altogether,
these results indicate that while the ERK1/2 pathway becomes activated under OGD conditions,
the PI3K/AKT pathway is dampened down, which collectively underlies the subsequent downstream
decrease in mTOR/S6K activation and autophagy activation.
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i re 5. Effects of OGDR, phytoestrogens, and 3-MA treatment on AKT and MAPK phosphorylation.
Western blots of 473SerP-AKT (A,B,D) and 202P-Thr- and 204P-Tyr-P-MAPK 42,44 (A–C) were performed
in extracts of cortical neurons subjected to 3 h OGD exposure (O) and 24 h OGDR (OR), in the absence
or presence of 5 mM 3-MA (A,B), or in the presence of 1 µM Gen or BE with or without 5 µM PD98059
or 5 µM LY294002 (C,D). Upper panels in (C,D) show representative Western blots. Lower panels
represent the quantitative analysis of indicated ratios and are mean ± SEM of three experiments,
each one performed in duplicate. Statistics in panel B compare the effect of OR over their respective
controls (***) or the effect of 3-MA in each condition versus respective conditions in the absence of
this compound (ooo). Statistics in panels (C,D) compare the effect of OR alone versus C24h and after
addition of phytoestrogens (***) or the effect of PD or LY in each condition versus the same conditions
in the absence of these compounds (ooo) at o p < 0.05, ** p < 0.01, *** p < 0.001 (one-way ANOVA test).
Although Gen and BE treatments increased mTOR phosphorylation, they did not have any
significant effect on the inhibition of AKT phosphorylation induced by OGDR (Figure 5D). This was
not a detection problem as we detected decreased pAKT after cotreating with the PI3K inhibitor
LY294002 (LY) but not with the MEK inhibitor PD98059 (PD) (Figure 5D). Interestingly, Gen and
BE significantly reversed the increase in MAPK phosphorylation induced by OGDR, which was not
further reduced by PD treatment, thus indicating a very strong effect of phytoestrogens on MAPK
phosphorylation (Figure 5C). Therefore, phytoestrogens behave as classical MAPK inhibitors rather
than classical activators of AKT phosphorylation.
4. Discussion
Autophagy is an important biological mechanism implicated in the regulation of numerous
fundamental cellular processes by enhancing the turnover of nonfunctional proteins and organelles [41].
Neuronal cells, like other eukaryotic cells, are dependent on autophagy for neuroprotection in response
to stress, but autophagy can also induce cell death in cerebral ischemia [42]. Recent studies have
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demonstrated that autophagy may induce neuroprotection following acute brain injury, including
ischemic stroke [9,43]. However, in some special circumstances, activation of autophagy can induce cell
death, playing a deleterious role in the etiology and progression of ischemic stroke [9,43,44]. Currently,
there are no therapeutic options against stroke that demonstrate efficient neuroprotective abilities.
For this reason, more indepth mechanism research is still needed about autophagy and its potential
use as a new therapeutic target for stroke [44,45].
In the present work, we have examined the contribution of autophagy in the context of OGD and
OGDR by first outlining its role in OGD-induced neuronal death. In addition, we have characterized
the cellular signaling pathways modulated by two naturally occurring phytoestrogens in regards to
their neuroprotective effects in this in vitro model and autophagy to assess their possible therapeutic
application in stroke.
Firstly, we addressed whether autophagy activation, a well-known event in experimental
ischemia [29], plays a pro-survival or a pro-death role in OGD–OGDR-induced neuronal damage.
We found that an OGD-induced decrease in cell viability and an increase in caspase-3 activity,
a well-known marker of apoptosis activation, were further potentiated on exposure to the autophagy
inhibitor 3-MA [35]. These results, along with the increase observed in lipidation of LC3I upon OGD
and OGDR, showed that autophagy activation is part of the endogenous pro-survival response to these
neuronal insults to protect neurons from enhanced apoptotic cell death upon OGD and OGDR.
Once we established the pro-survival role of autophagy in OGD and OGDR, we explored
whether the neuroprotective effects of phytoestrogens previously observed by us [29] and other
laboratories in in vitro [25] and in vivo models of cerebral ischemia [21,26,27,46,47] were related to
autophagy. First, we confirmed the neuroprotective properties of phytoestrogens by showing that
phytoestrogen treatment strongly ameliorated metabolic activity and reduced caspase-3 activation (i.e.,
apoptosis activation) after OGDR. However, this neuroprotection was blocked upon 3-MA cotreatment.
Given that 3-MA is an autophagy inhibitor, our results suggest that autophagy activation is required
for phytoestrogens to exert a neuroprotective effect and protect against OGDR-induced apoptosis.
To further confirm the activation of autophagy in OGD and OGDR conditions, the expression
levels of the canonical autophagy-initiator proteins Beclin 1 and BNIP3, which are transcriptionally
induced by the hypoxia-inducible factor (HIF1α) activation during ischemia [48], were analyzed in our
experimental setting. Both BNIP3 and Beclin-1 were initially identified as BCL2 or BCL-XL-interacting
proteins. Beclin-1 is part of a class III PI3-K containing complex that regulates autophagy induction, and
BCL2 inhibits autophagy by binding to Beclin-1. BNIP3 competes with Beclin-1 for binding to BCL-XL,
and its increased expression in hypoxia could disrupt pre-existing BCL-XL-Beclin-1 complexes, thereby
releasing Beclin-1 and activating autophagy [49]. We found a significant increase in Beclin-1 expression
at the protein level upon OGDR, along with a mild but significant increase in BNIP3 levels. Of note,
the mild changes in BNIP3 protein levels upon OGDR are in agreement with our data showing that
the increased expression of BNIP3 at the mRNA level occurs very transiently in OGD and decreases
rapidly during OGDR, unlike the mRNA expression of Beclin 1 which decreases more slowly (similarly
to those of HIF1α; data not shown), as previously shown [29]. Surprisingly, treatment with Gen and
BE during the period of oxygen and glucose resupply reduced Beclin-1 and BNIP3 levels, this effect
being more potent in association with 3-MA. These results indicate that while autophagy activation
is required for the neuroprotective effect of phytoestrogens, these lower autophagy at later stages,
at least as late as 24 h of treatment during OGDR. In agreement with these results, we found that
phytoestrogens increase Becn1 and BNIP3 mRNA levels at short periods of OGDR, while at longer
times, phytoestrogens lower the transcriptional levels of these two autophagic proteins. Therefore,
we propose that phytoestrogens exert a dual modulation on autophagy upon OGDR, depending on the
time point. Alternatively, phytoestrogens could reduce mitochondrial protein levels such as Becn1 and
BNIP3 as a simple off-target effect or act through mitophagy [49,50]. Future studies should address
whether chronically activating autophagy is detrimental in ischemic conditions and also if it prevents
the long-term neuroprotective effects of phytoestrogens.
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Recent studies on the expression of these genes, at the mRNA level, in models of rats with ischemia
or Alzheimer’s disease with ischemia [51–53] have also demonstrated great variability in the expression
of these autophagic and mitophagic genes in CA1 [51] and CA3 [52] regions of the hippocampus,
as well as in temporal lobe of the cerebral cortex [53]. In the latter, marked differences were reported
between the expression of Becn1 and BNIP 3 after a temporal course of 30 days after ischemia—that of
Becn1 being high at the beginning, with a tendency to decrease during the 30 days of the reperfusion
period, and that of BNIP3 having a tendency to ascend in the mid-term and then to decrease. Although
this model is not comparable to our in vitro model, changes in the expression of these genes at the
mRNA level are likely to influence the levels of these proteins involved in autophagy and mitophagy,
thus playing a relevant role in the response to brain ischemia in the cortex and hippocampus. In this
regard, measuring the expression of these genes at protein level at different times of OGDR and/or
the autophagic flux using a lysosomal inhibitor, such as bafilomycin or chloroquine, would provide
interesting information regarding the time-dependent effect of OGD, OGDR, and phytoestrogens
on autophagy.
Furthermore, we explored the potential involvement of mTOR/p70S6K as an important part
of the autophagy inhibition pathway [54] and its possible regulators (PI3K/AKT, MAPK, or AMPK)
in OGD and OGDR, as well as in the neuroprotective effects of phytoestrogens. In keeping with
previous results shown above, the protein levels of the active form of the autophagy blocker mTOR
(2448SerP-mTOR) dropped upon OGD, and so did those of its well-known substrate 389ThrP-p70S6K.
Of note, these effects were reverted by 3-MA. Overall, these results indicate that the mTOR/S6K
pathway participates in both the induction of OGD-triggered autophagy and in the 3-MA-induced
inhibition of OGD-triggered autophagy.
In the same way that the phytoestrogens inhibited the expression of proteins involved in the
initiation of autophagy, Beclin 1 and BNIP3, phytoestrogens were found to increase mTOR-activating
phosphorylation at 24 h of oxygen and glucose resupply treatment. Collectively, these results suggest
that phytoestrogens could play a dual role in the regulation of autophagy by acting as “autophagy
enhancers” when autophagy is a neuroprotective and pro-survival mechanism, and as “autophagy
inhibitors” when autophagy is a pro-death mechanism. The last mechanism could be mediated in an
mTOR-dependent manner.
To determine whether phytoestrogens act upstream of mTOR to lead to enhanced mTOR activation
at 24 h OGDR, we investigated their effect on the activated state of three well-documented pathways
that modulate mTOR activity, namely, AMPK, AKT, and MEK. First, we investigated the AMPK
pathway, which inhibits mTOR [55]. We observed an increase in AMPK phosphorylation under the
OGD condition, which was significantly reverted during OGDR. Furthermore, phytoestrogens and
BE reduced further OGDR-induced AMPK phosphorylation, indicating that this pathway is targeted
by phytoestrogens upstream to trigger mTOR activation after 24 h of OGDR. Second, we found
a remarkable decrease in AKT phosphorylation under OGDR conditions, which was unaffected
by 3-MA treatment. In contrast, 3-MA strongly inhibited AKT phosphorylation under control
conditions. While this effect could be related to an increase in neuronal death following autophagy
inhibition, we did not find evidence of increased cell death upon 3-MA treatment in control conditions.
Therefore, it is conceivable that other neuroprotective signaling pathways different to PI3K/AKT
could be at play to protect control cells from death when autophagy is inhibited in basal conditions.
Regarding the MAPK pathway, OGDR increased MAPK phosphorylation, although in this case,
3-MA did not have any effect. These results suggest that there is an opposite regulation by the
AKT and MEK/ERK signaling pathways in OGD–OGDR, and that only the PI3K/AKT pathway is
involved in OGDR-induced protective autophagy. However, these results could also be in agreement
with a recent noncanonical MEK/ERK pathway downstream of AMPK and upstream of TSC and
mTOR [56]. This MEK/ERK pathway regulates autophagy via regulating the Beclin 1 level through the
AMPK-MEK/ERK-TSC-mTOR pathway.
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Regarding the effect of phytoestrogens, Gen and BE did not have significant effects on the
OGDR-induced inhibition of AKT phosphorylation, yet they largely reversed the OGDR-induced
increase in MAPK phosphorylation. However, since the reversion of MAPK phosphorylation was not
abolished by PD98059, these data are not completely clear and need to be further clarified, although
these data seem to suggest that MAPK inhibition, rather than AKT activation pathways, could be
involved in the neuroprotective effects of phytoestrogens in OGDR.
Finally, both the Ras-ERK and PI3K-mTORC1 pathways represent key mechanisms for cells to
regulate cell survival and proliferation and, in addition to their independent signaling programs
that provide compensatory mechanisms, the pathways crosstalk extensively and regulate each other
both positively and negatively [57]. Pathway convergence and AGC kinase promiscuity have been
shown, and ERK and the AGC kinases, like AKT, often regulate the same substrates, yielding the
same phenotypic effects [45]. However, because no effects of MAPK inhibitors nor AKT inhibitors
have been observed in the effect of phytoestrogens on these pathways, our results seem to support
that phytoestrogens activate mTOR by reducing MAPK activation through mechanisms involving the
inhibition of Beclin-1 expression and AMPK phosphorylation rather than to a negative interaction
between ERK and AGC kinases, like AKT.
Recently many authors have been interested in studying the possible crosstalk between different
mechanisms of death in neurons, the current general consensus being that autophagy is initially
activated as a neuroprotective mechanism against necrotic and apoptotic neuronal death in situations
of brain damage such as ischemia, but that excessive accumulation of autophagosomes may become
a mechanism of death in later stages when the autophagic stress increased [58]. Thus, autophagy
would play a double role in the regulation of neuronal death. Our results support this hypothesis
that indicates an activation of autophagy when apoptosis and necrosis are severely activated, as is
the case with ischemia, and that when damage decreases with the time of reperfusion, autophagy
may have a role in promoting cell death. More recently, autophagy has also been seen to crosstalk
with other nonapoptotic or regulated necrotic death pathways such as necroptosis and pyroptosis [59],
which have also been reported in brain ischemia [60]. Thus, this would be an interesting topic to
consider in future studies. This knowledge will undoubtedly provide new therapeutic targets and new
mechanisms to understand the brain damage physiopathology. Signaling mediated by trophic factors,
hormones, and antioxidant and anti-inflammatory molecules, such as phytoestrogens, could be good
examples of modulators of these processes as they could regulate different mechanisms that mediate
neuronal demise, including necrosis, apoptosis, necroptosis, pyroptosis, and autophagy.
5. Conclusions
Overall, our findings provide renewed insight on the mechanism of action of autophagy in an
in vitro model of OGD and OGDR injury together with the molecular mechanisms underlying the
neuroprotective effects of phytoestrogens and estrogens, shedding light on the previously disputed
therapeutic potential of autophagy modulators and supporting the indepth study of mild autophagy
activators in in vivo models of ischemia [61].
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